InnoCare Pharma Limited (HKG:9969)

InnoCare Pharma Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 16, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	32,233	23,687	12,220	13,112	23,452	21,094
Market Cap Growth	92.83%	93.84%	-6.80%	-44.09%	11.18%	21.38%
Enterprise Value	26,180	17,849	6,114	4,689	14,292	15,136
Last Close Price	15.83	12.30	6.12	6.89	13.64	15.30
PE Ratio	37.43	33.13	-	-	-	-
PS Ratio	12.20	8.96	11.38	16.11	33.17	16.48
PB Ratio	3.74	2.75	1.70	1.66	2.71	3.04
P/TBV Ratio	3.87	2.85	1.78	1.73	2.75	3.09
P/FCF Ratio	2107.72	1548.92	-	-	-	-
P/OCF Ratio	345.23	253.70	-	-	-	102.87
EV/Sales Ratio	9.91	6.75	5.69	5.76	20.22	11.82
EV/EBITDA Ratio	41.98	30.23	-	-	-	-
EV/EBIT Ratio	52.02	35.46	-	-	-	-
EV/FCF Ratio	1711.96	1167.14	-	-	-	-
Debt / Equity Ratio	0.21	0.21	0.23	0.23	0.20	0.23
Debt / EBITDA Ratio	2.88	2.88	-	-	-	-
Debt / FCF Ratio	117.24	117.24	-	-	-	-
Net Debt / Equity Ratio	-0.70	-0.70	-0.80	-0.92	-0.98	-0.87
Net Debt / EBITDA Ratio	-10.29	-10.29	12.00	10.84	10.21	29.54
Net Debt / FCF Ratio	-397.39	-397.39	12.23	7.21	9.42	1821.44
Asset Turnover	0.24	0.24	0.10	0.07	0.07	0.18
Inventory Turnover	1.48	1.48	1.29	1.39	3.81	11.13
Quick Ratio	5.47	5.47	7.01	4.13	4.43	19.29
Current Ratio	5.83	5.83	7.45	4.21	4.48	19.49
Return on Equity (ROE)	8.89%	8.89%	-6.50%	-8.71%	-13.44%	-1.51%
Return on Assets (ROA)	2.79%	2.79%	-3.37%	-4.15%	-5.48%	-1.91%
Return on Invested Capital (ROIC)	24.61%	24.63%	-55.80%	-186.05%	-174.16%	-33.69%
Return on Capital Employed (ROCE)	4.80%	4.80%	-6.20%	-8.60%	-9.40%	-2.60%
Earnings Yield	2.22%	3.02%	-3.84%	-5.30%	-4.27%	-0.38%
FCF Yield	0.05%	0.07%	-3.86%	-7.73%	-3.82%	-0.02%
Payout Ratio	5.12%	5.13%	-	-	-	-
Buyback Yield / Dilution	0.24%	0.24%	0.67%	-15.31%	-8.29%	-41.21%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.